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Abstract
The aim of the article is to determine the essence of the logistics potential of a foreign trade activity of a pharmaceutical enter-
prise and justify the methods for determining it.
The materials used in the study include statistical data of the investigated pharmaceutical enterprises, namely JSC FF “Darnitsa”, 
PJSC NPC “Borschagovsky Chemical and Pharmaceutical Plant”, PJSC “Pharmak”, LLC “FC Zdorovia” and JSC “Lekhim-Kharkiv”. 
The study used methods of analysis and synthesis, generalization, content analysis, questionnaires and methods for assessing potential. 
The questionnaire was used to select indicators that should be part of the logistics potential of a foreign trade activity of a pharmaceutical 
enterprise.
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The experts were 100 leading specialists of pharmaceutical companies. They are all involved in foreign economic activity. 
Experts are gender–divided into women (73 %), men (27 %); by age: up to 25 years – 8 %, 25–35 years – 14 %, 35–45 years – 27 %, 
45–55 years – 36 %, over 55 years – 15 %; by experience: up to 5 years – 11 %, 5–10 years – 15 %, 10–20 years – 32 %, 20–30 years – 36 %, 
over 30 years – 6 %. The experts’ conclusions are valid, the coefficient of concordance is 0.86, and the Pearson test exceeds the table value.
The essence of the definition of “potential of logistics of pharmaceutical enterprise’s foreign trade activity” is investigated. The 
types of logistics potential of foreign economic activity and indicators that are appropriate to use for determining the level of develop-
ment of the logistic potential in foreign economic activity are offered.
The potential of logistics of foreign trade activities of pharmaceutical enterprises consists of the potentials of logistics in the 
field of export and import. The system of indicators for measuring the logistics potential of a foreign trade activity of a pharmaceutical 
enterprise contains indicators selected through content analysis and questionnaires.
The method of estimation of logistics potential in foreign economic activity of pharmaceutical enterprise is offered.
Keywords: potential, logistics, foreign economic activity, pharmaceutical enterprise.
DOI: 10.21303/2504-5679.2019.00997
1. Introduction
In the current dynamic conditions, among the main causes of exacerbation of problems 
with the sale of pharmaceutical products, reducing the cost of production and marketing of drugs 
and increase its efficiency, scientists highlight the restructuring of the world economy, the intense 
development of the pharmaceutical market, the growing role of economic unions (alliances) and 
the activation of economic ties between pharmaceutical companies, suppliers of active pharma-
ceutical ingredients, basic and auxiliary materials, distribution oramy, active dissemination of new 
information and communication technology and logistics, change directions and volumes of inter-
national cargo and complexity of production processes, enterprises themselves inside and outside, 
that is, foreign economic activity.
Correctly built foreign economic activity of the enterprise due to the formation and support 
of business relations at the international level will bring him additional economic benefits. But it 
must be taken into account that the enterprise should carry out this activity only in those countries 
and with that partner that are the most profitable for a specific period of time.
Domestic pharmaceutical enterprises are distinguished by their unique geographical loca-
tion at the crossroads of trade routes, therefore they can receive significantly more benefits from 
globalization and international cooperation. This predetermines the need to develop effective ap-
proaches to managing the processes of purchasing, transportation, storage and marketing of prod-
ucts, actualizes the need to use a scientific approach to improving the economic and organizational 
mechanism for the development of logistics processes in managing the movement of material, 
financial and information flows.
Theorists and practitioners [1, 2] have already repeatedly proved that today it is logistics that 
provides the appropriate level of enterprise potential, together with natural conditions, resources, 
means and values, provides opportunities for more complete use of resources and, consequently, 
economic development for gaining competitive advantages in the market environment. So, it is 
quite clear that logistics from fundamental science is gradually turning into the practical dominant 
of the pharmaceutical enterprise, and the effective use of logistics tools can reduce costs, improve 
productivity and improve customer service. Using logistics approaches allows enterprises to carry 
out productive activities, and increases the role of the logistics component in the process of rational 
capacity building.
The aim of the article is to determine the essence of the logistics potential of the foreign 
economic activity of a pharmaceutical company and the rationale for its determination.
2. Materials and methods
The materials used in the study include statistical data of the investigated pharmaceutical 
enterprises, namely JSC FF “Darnitsa”, PJSC NPC “Borschagovsky Chemical and Pharmaceutical 
Plant”, PJSC “Pharmak”, LLC “FC Zdorovia” and JSC “Lekhim-Kharkiv”.
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The study used methods of analysis and synthesis, generalization, content analysis, ques-
tionnaires and methods for assessing potential.
The experts were 100 leading specialists of pharmaceutical companies involved in foreign 
economic activity, among which women – 73 %, men – 27 %. According to age, the experts were 
divided as follows: up to 25 years old – 8 %, 25–35 years old – 14 %, 35–45 years old – 27 %, 
45–55 years old – 36 %, over 55 years old – 15 %. According to the experience, experts were 
divided – up to 5 years – 11 %, 5–10 years – 15 %, 10–20 years – 32 %, 20–30 years – 36 %, over 
30 years – 6 %. Expert conclusions are justified, the concordance coefficient is 0.86, the Pearson 
criterion exceeds the table value.
The questionnaire was used to select indicators that should be part of the logistics potential 
of a foreign trade activity of a pharmaceutical enterprise. Score was scored on a ten-point scale 
ranging from the lowest (1 point) to the highest (10 points). Indicators with a weighted average of 
the expert evaluation score less than 3 were not used in the subsequent calculations.
Experimental procedures.
The study was conducted in five stages. At the first stage, based on the study of the opinions 
of scientists and the specifics of the pharmaceutical sector of the healthcare industry and the activ-
ity of pharmaceutical enterprises, the definition of “logistics potential of foreign economic activity 
of the pharmaceutical enterprise” was defined. The second stage is devoted to the study of the lo-
gistics potential composition of the foreign economic activity of a pharmaceutical company, which 
was carried out on the basis of content analysis and questionnaires. The third stage is an assessment 
of the logistics potential of the foreign economic activity of a pharmaceutical company. The fourth 
stage is devoted to determining the factors influencing it. In the fifth stage, the development of an 
optimal strategy for developing the logistics potential of foreign economic activity of the pharma-
ceutical enterprise was done.
3. Results
The analysis of publications on this range of issues indicates that there is little sci-
entific work in the field. A number of issues remain under-researched, such as: theoretical 
substantiation of the essence of the logistics potential of a pharmaceutical enterprise (PhE), 
especially those that are subjects of foreign economic activity [3, 4]; lack of a unified sys-
tematic approach to the mechanism of its formation [5], operation and development, lack of 
applied development of organizational measures to optimize the management of logistics po- 
tential [6, 7]. 
In foreign publications, the potential is mostly regarded as a resource, but, for the most 
part, relative to a country or region (military, industrial, natural) [8, 9], only some [10, 11] 
understand the degree of power (hidden opportunities) in any respect. Domestic economic 
literature [12, 13], on the contrary, is more inclined to understand it as opportunities, available 
forces, reserves and means that can be used to achieve a specific goal of the enterprise [14, 15]. 
However, some scholars [16, 17] argue that the potential is more properly called the set neces-
sary for the functioning and development of a system of different types of resources. There-
fore, despite the diversity of views on the essence of the concept and based on the general 
features of each interpretation, we can agree that the potential, in any case, means the presence 
of someone (person, staff, enterprise, society) hidden to activities in certain areas that have 
not yet emerged [17, 18]. 
Home authors, considering the functional features and structure of logistic processes by 
subject characteristics (personnel logistics, logistics of materials and finished goods, energy 
and information flows), determine the logistical potential of the enterprise as the maximum 
productivity (functional capacity) of systemically integrated subdivisions, all subdivisions, in 
space and time movement of personnel, materials and finished products, energy and informa-
tion flows [19, 20].
The place of the FEA logistics potential in the structure of the PhE logistics potential in a 
formalized form is reflected as follows:
Original Research Article:
full paper
(2019), «EUREKA: Health Sciences»
Number 5
30
Pharmacology, Toxicology and Pharmaceutical Science
{ }
{ }
lFEA 1–exp l imp
lFEA prod warehouse tr purch pal inf pers serv
lFEA 1 exp LFEA 1 exp 1 imp B 1 imp B
1 imp warehouse 1 imp warehouse
P f P ;P ;
P f A ;B ;C ;D ;l ;F ;H ;K ;
P P P P P A P A ;
P B ;P B
−
− − − −
− −
≡
≡
⊃

∧ ⊃ ∧ ≠

⊃

∧


≠


∩ ∵
Pl FEA – many components of the logistics potential of foreign economic activity of a pharmaceutical 
company; P
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 and P
l-imp 
– a set of components of the logistics activity potential in the pharmaceuti-
cal export import sphere respectively; Aprod, Вwarehouse, Сtr, Dpurch, Isal, Finf, Hpers, Kserv  – set of elements 
in the structure of the potential of logistics activity in the field of export and import of the pharma-
ceutical enterprise, respectively, which is represented by the potential of production, warehouse, 
transport, purchasing, sales, information, personnel and logistics services.
Foreign Trade Logistics Potential is composed of export and import logistics. The system of 
indicators for measuring the logistics potential of the FEA of a pharmaceutical enterprise is shown 
in Fig. 1. The scorecard includes indicators selected through content analysis and questionnaire 
surveys.
Fig. 1. System of indicators of measuring the potential of logistics of  
pharmaceutical enterprise FEA
Based on the calculated synergy coefficient, the enterprise monitors potential development 
in order to quickly respond to negative trends. The value of the synergy coefficient is in the range 
from 0<β<1. If the estimated β>1, then the enterprise for a certain time has become more efficient 
in managing its potential. If 0.8<β<1, then it is necessary to take measures to improve logistics. If 
0.79<β, then it is necessary to take strict measures for the efficient functioning of logistics and the 
enterprise as a whole.
The norm is the best level of PhE logistics potential for a certain period of time.
The dynamics of the logistics indicators of foreign economic activity of the studied PhE are 
shown in Fig. 2.
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Fig. 2. Dynamics of integral index of logistics of FEA of the investigated PhEs
4. Discussion
Taking into account the theoretical positions and views of scientists, we consider it ap-
propriate to use the definition of the logistics potential of a pharmaceutical enterprise subject to 
foreign economic activity, according to which it is a dynamically balanced system of resources 
and competencies, the effective use of which is based on the implementation of the optimization 
and integration properties of logistics (coordination of activities of functional units in organizing 
the movement of material, financial, information on resources per hundred actions of the logistic 
chain), determines the possibility of effective activity of the enterprise in the foreign market to 
ensure its development.
The proposed approach differs from the others [4, 20] by the complexity of the approach to 
the spheres of logistic activity of the enterprise, secondly, in the works [9] only quantitative indi-
cators are taken into account.
As noted above, to date, insufficient attention has been paid to the problem under study. The 
vast majority of scientists investigate the level of logistic potential of the pharmaceutical enterprise 
as a whole, others have studied the potential of foreign economic activity of enterprises without 
taking into account the specificity of the pharmaceutical enterprise, its social orientation and the 
features of storage and transportation of finished medicines.
The proposed methodology differs from the existing ones and the set of indicators used to 
assess the level of potential. The obtained results allow us to conclude that the logistics of foreign 
economic activity of the studied domestic PhEs is quite different, since the value of integral indi-
cators ranges from 0.59 to 0.91.
Scale of assessment of the status of FEA logistics by the magnitude of the integral indicator 
has the following ranges: from 0 to 0.25 – unsatisfactory level of logistics of FEA; from 0.26 to 
0.50 – average level of foreign trade logistics); from 0.51 to 0.75 – the level of foreign trade logistics 
is above average; from 0.76 to 1 – high level of FEA logistics.
Based on the calculations, the state logistics FEA any of the studied pharmaceutical 
enterprises can be described as high. Positive trend has all investigated pharmaceutical en-
terprises, rather high indicators are characteristic for PJSC “Pharmak”, PJSC “Darnitsa” and 
PJSC NPC “Borschagovsky HFZ”.
Therefore, we can conclude that the need to take measures to improve the level of logistics 
FEA at domestic pharmaceutical enterprises logistic potential, like all types of potentials inherent 
in AF, is formed under the influence of a large number of factors that exert both positive and neg-
ative effects, as well as constantly changing, which include not only the internal environment (the 
size of the pharmaceutical enterprises, the range of drugs manufactured enterprises, infrastructure 
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development, etc.) and macroenvironment (demand, entry into the pharmaceutical market, com-
petitors, etc.).
5. Conclusions
1. The definition of “logistics potential of foreign trade activity of pharmaceutical enter-
prise” is defined, under which it is expedient to understand a dynamically balanced system of 
resources and competencies, the effective use of which is based on the realization of optimization 
and integration properties of logistics (coordination of activity of functional units during the orga-
nization of movement of material, financial resources, by stages of the logistics chain), determines 
the possibility of effective activity of the enterprise in the foreign market to ensure its development.
2. A system of indicators has been developed to determine the level of development of lo-
gistics potential of foreign economic activity of a pharmaceutical enterprise. Thus, the logistics 
potential of a foreign trade activity of a pharmaceutical enterprise consists of the logistics potential 
in the sphere of export and the potential of logistics in the sphere of import. Quantitative indica-
tors for measuring the potential of logistics in the export field include export volumes, number of 
partners and number of export operations; quality indicators include the level of logistical services, 
the rate of fulfilment of contractual obligations (in terms of quality, time, quantity) and the breadth 
of coverage of the markets for pharmaceutical products. Quantitative indicators for measuring the 
potential of import logistics include import volumes, number of partners, and number of export 
operations; to quality indicators – the level of logistic service, the rate of fulfilment of contractual 
obligations (in quality, time, quantity).
3. A system of indicators has been developed to determine the proposed methodology for 
evaluating the logistics potential of a foreign trade activity of a pharmaceutical enterprise, which 
takes into account the normative and real level of its development and the synergy coefficient.
4. The scale of estimation of the state of logistics of FEA by the magnitude of the integral 
index is offered, which allows to estimate the level of development and to develop directions of 
improvement on its basis.
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